212 related articles for article (PubMed ID: 8763633)
1. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
Marzullo C; Bourderont D; Dorr R
Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
[TBL] [Abstract][Full Text] [Related]
2. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
Schlebusch H; Jarausch J; Domke I
Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
[TBL] [Abstract][Full Text] [Related]
3. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
Li JH; Wu ZG; Xu JQ; Zhou Y
Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of five immunoassays for the determination of digoxin in serum.
Sasieta M; Jimeno P
Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):935-40. PubMed ID: 8960471
[TBL] [Abstract][Full Text] [Related]
5. Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range.
Morris RG; Jones TE; Goldsworthy SJ; Wagner TJ; Ho H; Horowitz JD
Ther Drug Monit; 2006 Jun; 28(3):454-7. PubMed ID: 16778733
[TBL] [Abstract][Full Text] [Related]
6. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
Li J; Wu Z; Xu J; Zhou Y; Chu X
Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
[TBL] [Abstract][Full Text] [Related]
7. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
Heise HR; Vorwerk P; Fritsche K; Richter R
Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
[TBL] [Abstract][Full Text] [Related]
8. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
[TBL] [Abstract][Full Text] [Related]
9. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
[TBL] [Abstract][Full Text] [Related]
10. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
Seccombe DW; Pudek MR; Humphries KH
J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
[TBL] [Abstract][Full Text] [Related]
11. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
[TBL] [Abstract][Full Text] [Related]
12. Increased digitalis-like immunoreactive substances in neonatal plasma measured using fluorescence polarization immunoassay.
Ijiri Y; Hayahi T; Ogihara T; Ohi K; Suzuki K; Tamai H; Kitaura Y; Takenaka H; Tanaka K
J Clin Pharm Ther; 2004 Dec; 29(6):565-71. PubMed ID: 15584945
[TBL] [Abstract][Full Text] [Related]
13. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
Lackner TE; Lau BW; Parvin C; Valdes R
Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an immunoturbidimetric assay of serum digoxin without sample pretreatment.
Ruiz R; Borque L; Soria AG; Córdova MA; Asolo B
Eur J Clin Chem Clin Biochem; 1995 Mar; 33(3):171-5. PubMed ID: 7605830
[TBL] [Abstract][Full Text] [Related]
15. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
Matheke ML; Valdes R
Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
[TBL] [Abstract][Full Text] [Related]
16. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
Greenway DC; Nanji AA
Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
[TBL] [Abstract][Full Text] [Related]
17. Endogenous glycosides in critically ill patients.
Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
[TBL] [Abstract][Full Text] [Related]
18. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
Ng PK; LeGatt D; Coates J; Collins-Nakai RL
Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
[TBL] [Abstract][Full Text] [Related]
19. Inaccuracies in digoxin measurement.
Cook JD; Koch TR; Cook MS; Knoblock EC
Clin Biochem; 1988 Dec; 21(6):353-7. PubMed ID: 3233747
[TBL] [Abstract][Full Text] [Related]
20. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
Mojaverian P; Green PJ; Jhangiania RK; Chase GD
J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
